Princeton-based Slayback Pharma LLC, a pharmaceutical research and development company, announced it has appointed Dr. Girish Jain as senior vice president and head of global R&D.
Jain will be based out of the company’s Hyderabad, India office.
Prior to Slayback, he was president and head of R&D at Alkem. Before that, he was at Wockhardt as senior vice prseident and head of R&D.
“Girish is both an excellent scientist and an inspiring leader. He leads from the front and rolls up his sleeves to get the work done. I am delighted to have Girish join us to inspire and lead our motivated R&D team,” Ajay Singh, CEOa and president of Slayback, said.
“I am very excited to work with highly motivated team of Slayback and expect to achieve greater heights for the organization working together with the team,” Jain said.